Diversity in Cancer Research: Getting Started
Learn how to start ensuring the membership and leadership of your NCI-designated cancer center reflect the population you serve.
The Future of Phase I Oncology Studies
Oncology drugs in phase I trials are usually conducted on patients with cancer due to their inherent risk. Advarra IRB member Ran Goldman expands: